Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NeuroPace (NPCE) Current Leases (2022 - 2025)

Historic Current Leases for NeuroPace (NPCE) over the last 4 years, with Q3 2025 value amounting to $2.1 million.

  • NeuroPace's Current Leases rose 1394.44% to $2.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.1 million, marking a year-over-year increase of 1394.44%. This contributed to the annual value of $1.9 million for FY2024, which is 1432.08% up from last year.
  • Per NeuroPace's latest filing, its Current Leases stood at $2.1 million for Q3 2025, which was up 1394.44% from $2.0 million recorded in Q2 2025.
  • NeuroPace's 5-year Current Leases high stood at $2.9 million for Q2 2022, and its period low was $692000.0 during Q3 2022.
  • For the 4-year period, NeuroPace's Current Leases averaged around $1.8 million, with its median value being $1.7 million (2024).
  • Over the last 5 years, NeuroPace's Current Leases had its largest YoY gain of 12716.76% in 2023, and its largest YoY loss of 4888.42% in 2023.
  • NeuroPace's Current Leases (Quarter) stood at $1.4 million in 2022, then grew by 14.98% to $1.6 million in 2023, then grew by 14.32% to $1.9 million in 2024, then rose by 10.27% to $2.1 million in 2025.
  • Its Current Leases stands at $2.1 million for Q3 2025, versus $2.0 million for Q2 2025 and $1.9 million for Q1 2025.